Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood|August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World AnalysisTai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.
Blood Cancer Journal|September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology|May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.
Oncotarget|August 17, 2016
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)Chi-Yuan Yao, Hsin-An Hou, Tzung-Yi Lin, et al.
Oncotarget|January 27, 2016
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHsin-An Hou, Chieh-Yu Liu, Yuan-Yeh Kuo, et al.
Blood|November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implicationsHsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Annals of Hematology|September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.
Bone Marrow Transplantation|October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remissionFeng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
Blood|August 11, 2011
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogeneticsWen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, et al.
Pageof 5